ALGBE.PA Global Bioenergies (EURONEXT) €0.02: oversold bounce, eye €0.03 target

ALGBE.PA stock trades at €0.0185 intraday on EURONEXT on 13 Mar 2026, marking a deeply oversold level after multi-period declines. The current price sits near the 52-week low of €0.0173 with a 50-day average of €0.01982, creating a short-term mean-reversion opportunity for active traders. Volume today is 32,615 shares versus an average of 81,160, and recent fundamentals show EPS -0.32, underlining high operational risk. We assess a measured oversold bounce trade with clear entry, stop and a short-term price target of €0.03

Intraday snapshot: why ALGBE.PA stock looks oversold

The intraday picture shows Global Bioenergies SA (ALGBE.PA) trading at €0.0185 with a day range €0.0185-€0.0201 and thin liquidity, volume 32,615. Price is well below the 200-day average €0.30668, reflecting a collapse from the year high €1.57. These extremes create an oversold technical profile where short-term bounces are common, but low float and wide bid-ask spreads raise execution risk.

Catalysts and recent ALGBE.PA earnings context

Global Bioenergies reported last earnings on 02 Feb 2026 with EPS -0.32 and weak revenue per share €0.01989, reinforcing negative sentiment. No major corporate news has reversed the downtrend; the company continues pilot projects converting plant feedstocks to isobutene. For company details see the corporate site Global Bioenergies. Earnings and project updates remain the primary catalysts for any sustainable recovery.

Technicals, Meyka AI grade and trading signals for ALGBE.PA stock

Technically, momentum is compressed and standard indicators show oversold extremes and low computed RSI readings on sparse data. Meyka AI rates ALGBE.PA with a score out of 100: 68.40 (Grade B, Suggestion: HOLD). This grade factors S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Traders should note short-term resistance near €0.03 and strong selling pressure around the 50-day average €0.01982.

Valuation and balance-sheet metrics that matter

Market cap is €335,375.00 with shares outstanding 18,128,388, book value per share €0.09336, and cash per share €0.26822. Key ratios include P/S 0.93, PB 0.20, and debt-to-equity 3.34, signalling capital structure stress. Operating cash flow per share is -0.41402, which supports the view that any bounce is speculative until cash generation improves or financing is secured.

Oversold bounce strategy and precise trade plan

For a disciplined oversold bounce play, consider a scaled entry at €0.0185–€0.0200, tight stop-loss at €0.0150, and layered profit targets at €0.03 (first) and €0.06 (secondary). Position sizing should limit risk to 1–2% of portfolio capital per trade due to extreme volatility and low liquidity. Watch for volume confirmation above 80,000 shares as validation of a sustainable move.

Risks, sector outlook and upside scenarios

Key risks include continued dilution, project execution delays and high leverage implied by debt/equity 3.34. The Utilities sector in Europe has shown positive relative performance YTD, but Global Bioenergies operates in a niche bio-chemical subsegment where recovery depends on contract wins. Upside scenarios require sustained volume, positive operational updates and clearer funding; absent those, downside remains likely.

Final Thoughts

Short-term traders can treat ALGBE.PA stock as a high-risk oversold bounce candidate while longer-term investors must weigh financing and execution risk. Meyka AI’s forecast model projects a near-term bounce to €0.03, versus the current price €0.0185, implying an upside of 62.16% for a successful mean reversion. A 12-month recovery scenario from the model shows a stretch target of €0.10, implying 440.54% upside, but these are model-based projections and not guarantees. Given cash per share €0.26822, negative operating cash flow and EPS -0.32, any position should be small, risk-managed and contingent on volume confirmation or positive company updates. We use Meyka AI as an AI-powered market analysis platform to quantify the bounce odds, but investors should perform independent due diligence and expect high volatility on EURONEXT in EUR.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.